Global Biomarker of Disease Market Growth (Status and Outlook) 2024-2030
The global Biomarker of Disease market size is projected to grow from US$ 31640 million in 2024 to US$ 79080 million in 2030; it is expected to grow at a CAGR of 16.5% from 2024 to 2030.
Key features:
- Omics, proteomics, and metabolomics technologies in biomarker discovery and disease diagnosis.
- Applications in risk assessment, molecular diagnostics, DNA fingerprinting, and other molecular applications.
- Assists pharmaceutical companies with drug discovery and validation.
- Market forecast for Biomarker of Disease sales from 2023 to 2029.
Segmentation by Type:
- Sample Preparation
- Assay Development
- Biomarker Validation and Testing
- Others
Segmentation by Application:
- Pharmaceutical Companies
- Government & Private Research Institutes
- Academic Institutes
- Medical Device Manufacturing Companies
- Others
Market by Region:
- Americas
- APAC
- Europe
- Middle East & Africa
Company Coverage:
- Aushon Biosystem
- Bio-Rad Laboratories
- Thermo Fisher Scientific Inc
- Siemens AG
- Eisai Co. Ltd
- Roche Diagnostics Limited
- Abbott Laboratories, Inc
- Epistem Ltd
- Ge Healthcare
- Agilent Technologies Inc
Key Questions Addressed in this Report:
Frequently Asked Questions
Biomarker of Disease report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biomarker of Disease report is categorised based on following features:
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market
Biomarker of Disease report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.